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Abstract
Aim. Rotavirus is recognized as the main cause of acute gastroenteritis in children under 
5 years old, representing a considerable public health problem with a great impact on 
social and public health costs in developed countries. This study aims to assess the fre-
quency and the epidemiological aspect of the hospitalization associated with Rotavirus-
gastroenteritis in Lombardy, Northern Italy, from 2005 to 2011. 
Methods. The Lombardy Hospital Discharge Database was inquired from the official 
data of the Italian Ministry of Health and investigated for acute gastroenteritis (ICD9-
CM code for bacteria, parasitic, viral and undetermined etiologic diarrhea) in primary 
and secondary diagnosis in children ≤ 5 years, between 2005 and 2011. 
Results. Out of the 32 944 acute-gastroenteritis hospitalizations reported in Lombardy, 
the 50.8% was caused by Rotavirus infection; of these, the 65.5% were reported in pri-
mary diagnosis. The peak of Rotavirus-gastroenteritis hospitalization was observed in 
February-March in children < 2 years old, with a cumulative prevalence of 64.5%. Pa-
tients admitted to hospital with diarrhea of undetermined etiology (about 14% of overall 
acute-gastroenteritis) showed epidemiological characteristics similar to the Rotavirus-
gastroenteritis, suggesting that the virus infection could also be involved in at least some 
of these.
Conclusion. Our data confirm that Rotavirus are the most important agents involving 
in acute gastroenteritis hospitalizations. The use of Hospital Discharge Database had 
proved to be a simple tool to estimate the burden and to describe the epidemiological 
characteristics of Rotavirus gastroenteritis and could be used as a surveillance activity be-
fore and after the introduction of mass vaccination at national and regional level in Italy. 
INTRODUCTION
Human group A Rotaviruses (RV) belong to the Reo-
viridae family and are recognized as the major cause of 
acute gastroenteritis (AGE) and dehydration in chil-
dren worldwide. It is estimated that RV infection causes 
approximately 450 000 deaths annually in children < 5 
years old mostly in developing countries; in industrial-
ized countries the infection represents a relevant public 
health problem due to the elevated morbidity and social 
and health costs associated [1].
The World Health Organization (WHO) recommends 
to include RV immunization in all vaccination programs, 
in order to prevent the infection and to reduce the ex-
tent of the disease [2]. Vaccine formulations available 
had shown high safety and efficacy in large-scale trials 
[3, 4] so since 2008 the European Society for Paediatric 
Infectious Diseases (ESPID) and the European Society 
for Paediatric Gastroenterology, Hepatology, and Nutri-
tion (ESPGHAN) endorse the introduction of RV vac-
cines for all healthy infants in Europe [5]. 
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An European multicenter prospective study has shown 
that in Italy RV infection account more than 1/3 of all 
children aged < 5 years hospitalized for AGE, especially 
infants between 3-36 months of years [6]; nevertheless, 
nowadays RV are not included in the Italian National 
Plan of Vaccinations (NPV). The offer of the RV vaccine 
remains highly heterogeneous in the country and the 
vaccination has not been identified as a priority. Some 
Italian regions offers the RV vaccination in co-payment 
or the vaccine are offered free of charge for few risk-
groups identified in the population. During the drafting 
of this paper, only Sicily region has been introduced the 
vaccine in its routine immunization schedule [7].
The impact of Rotavirus gastroenteritis (RVGE) in 
children in Italy had been estimated through the use of 
ICD9-CM code extraction from HDD (Hospital Dis-
charge Database) in previous studies [8-12], but Lom-
bardy region (North-West Italy) was no included. 
This study aims to estimate the impact of RVGE 
hospitalizations in Lombardy and to investigate the 
epidemiological characteristics of RVGE, analyzing the 
HDD from 2005 to 2011. The adoption of HDD to 
monitor RVGE cases and the potential impact of vacci-
nation on a large scale in Lombardy are also discussed.
MATERIALS AND METHODS
Study population
The data presented in this study were obtained ret-
rospectively from existing databases established by the 
Ministry of Health, in accordance with the national reg-
ulations related to clinical research. In agreement with 
the Italian law Decree no. 196/2003, it was not neces-
sary to obtain informed consent of patients or specific 
authorization by the Ethics Committees, because the 
anonymity of data was assured throughout the study. 
The data were collected in an electronic form. The 
study was conducted in accordance with the Helsinki 
Declaration of 1975.
The ICD-9-CM diagnoses and codes were obtained 
by Lombardy’s HDD [13] and were analyzed to iden-
tify children (1 month-5 years) admitted to hospital 
with AGE from 2005 to 2011. Neonates younger than 
< 1 month were not included in the study, because no 
specific code exists for the identification of the illnesses, 
of any etiologic situation, which occur in this age group. 
The AGE hospitalizations were extracted by one of the 
seven possible diagnoses associated with patient: pri-
mary diagnosis was indicated with PD whereas the fol-
lowing 6 secondary diagnoses were indicated as SD. The 
ICD9-CM codes encompassed both etiologically deter-
mined diarrheas including bacterial [001-005, exclud-
ing 003.2 and 008.0-008.5], parasitic [006-007, exclud-
ing 006.2-006.6], or viral [008.6 and 008.8] cases, and 
diarrhea of undetermined etiology (NDGE), including 
cases of possible infective origin (8009.0-8009.3) and 
those presumably non-infective (558.9). 
The specific ICD9-CM code for RVGE is 008.61, 
and the NDGE includes codes from 8009.0 to 8009.3 
and 558.9. 
Statistical analysis 
Diarrhea coded hospitalizations for RVGE and 
NDGE were examined by gender, age group (1-3, 4-6, 
7-11, 12-23, 24-35, 36-47, 48-59 and 60-71 months), 
and month of discharge in PD and SD and tested by 
the chi-square test. A p-value < 0.05 was considered to 
indicate statistical significance (two-tailed test). The 
variables were expressed as frequency and percentage 
with the exact binomial 95% confidence intervals (CI). 
AGE and RVGE hospitalization rates were calculated 
as the estimated number of hospitalizations per 100 
000 children below 6 years of age based on estimates 
of the resident population in Lombardy for the corre-
sponding year retrieved by the National Institute of Sta-
tistics (ISTAT) website [14]. All statistical analyses were 
done using the OPENEPI software, version 3.03 up-
dating 2014/09/22 (Copyright (©) 2003, 2008 Andrew 
G. Dean and Kevin M. Sullivan, Atlanta, GA, USA). 
RESULTS
From 2005 to 2011, 32 944 AGE hospitalizations 
were reported in Lombardy. In total, 16 738 cases were 
diagnosed as RVGE, equal to 50.8% (95% CI 50.27-
51.35) of total AGE cases. Of these, 10 961 (65.5%; 
95% CI 64.76-66.2) were reported as PD and 5777 
(34.5%; 95% CI 33.8-35.24) as SD. On average, 2391 
cases of RVGE were reported yearly throughout the 
study period. 
The median annual rate of AGE and RVGE hospital-
izations in children ≤ 5 years old was 4812 in 572 607 
inhabitants (0.8%; 95% CI 0.81-0.86) and 2462 (0.4%; 
95% CI 0.41-0.44), respectively. The overall AGE hos-
pitalization rate was 825/100 000 while RVGE rate was 
419/100 000 (1 child every 238). 
Overall, 18 321 in 32 944 AGE cases (55.6%; 95% 
CI 55.08-56.15) occurred in males and 14 623 (44.4%; 
95% CI 43.85-44.92) in females (p < 0.001), whereas 
9292 in 16 738 RVGE hospitalization (55.5%; 95% CI 
54.76-56.27) were recorded in males and 7444 (44.6%; 
95% CI 43.72-45.23) in females (p < 0.001). 
The monthly course of the RVGE admissions showed 
a recurrent seasonal trend during the whole period of 
study, between December and April, with a peak in 
February-March (Figure 1b)
Considering RVGE (notified in either PD or SD), 10 
802 in 16 738 hospitalization (64.5%; 95% CI 63.81-
65.26) were happened within the first two years of life. 
The rate of RVGE hospitalizations showed an increase 
in the children up to the 12-24 months age class fol-
lowed by a reduction in the higher group (Table 1).
In the cohort of 1-11 months old, RVGE cases were 
recorded in SD more frequent than in PD (37.7% vs 
29.1%, p < 0.001) (Table 1). In the Table 2 the distribu-
tion of RVGE in PD and SD linked with ages and sea-
sonal trend are shown; out of 3469 RVGE occurred in 
children below 11 months old and during winter season 
– from December to March, 1498 cases were recorded 
in SD (43.2%; 95% CI 41.22-44.5) showing an higher 
rate than those recorded in the other seasons – from 
April to November (678/1889 equal to 35.7%; 95% CI 
33.76-38.08) (p < 0.001), while out of 6194 RVGE re-
corded in SD in children > 12 months old, 1382 hospi-
talization (22.3%; 95% CI 21.29-23.37) occurred from 
December to March indicating a lower rate than those 
Laura Pellegrinelli, Laura Bubba, Valeria Primache, Iacopo Chiaramonte et al.
O
r
ig
in
a
l
 a
r
t
ic
l
e
s
 a
n
d
 r
e
v
ie
w
s
348
recorded from April to November (2219/5176 equal to 
42.9%; 95% CI 41.53-44.22) (p < 0.001) (Table 2).
Through the study period, 4786 in 32 944 AGE hos-
pitalizations (14.5%; 95% CI 14.15-14.91) were char-
acterized as NDGE, among which 3173 (66.3%; 95% 
CI 64.95-67.62) were notified in PD and 1613 (33.7%; 
95% CI 32.38-35.05) in SD.
The epidemiological characteristics of RVGE and 
NDGE cases were compared. With respect to the dis-
tribution by age group, RVGE and NDGE hospitaliza-
tions showed overall similar values  (p > 0.05), except in 
the age group 48-59 months (p < 0.05), where the rate 
of NDGE was greater than RVGE (Figure 1a). Con-
cerning the seasonal distribution, NDGE presented a 
similar trend to that observed for RVGE, with a peak 
between January and March, which however was re-
markably smoother (Figure 1b).
DISCUSSION
Before the introduction of mass vaccination against 
RV in the community, it is important to estimate the 
burden of the infection and the social and economic im-
pact of RVGE hospitalizations, as well as the potential 
benefits of vaccine deriving from the expected reduc-
tion of admissions to hospital. In Italy, no national sur-
veillance system of AGE or RVGE infection in children 
is in place, and accurate estimates of the incidence of 
RVGE is difficult to achieve.
This is the first study performed by the use of the 
ICD9-CM conducted in the whole Lombardy region 
for seven consecutive season, and its results indicate 
that HDD may be an easy and without additional cost 
tool for estimating RVGE hospitalizations in the popu-
lation. As suggested by Marchetti et al. [9], the exami-
nation of all the diagnoses (PD and SD) available for 
the hospitalized patient could in fact increase the sensi-
tivity of the measurement. 
In Lombardy, about two thirds of RVGE hospitaliza-
tions were notified in PD. Because the SD is related 
to conditions that may either be present at the time of 
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Figure 1
Comparison between Rotavirus gastroenteritis (RVGE) and diarrhea of undetermined etiology (NDGE) in the study population in 
Lombardy, 2005-2011. a) Prevalence of RVGE vs NDGE by age. b) Prevalence of RVGE vs NDGE by month.
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admission or develop later, it is sometimes difficult to 
identify the real proportion of nosocomial RVGE, as oc-
curred also in this study.
Our data confirm that RV was the most important 
agent involved in AGE hospitalization, being present 
in more than half of the cases investigated. On a popu-
lation basis, these data indicate that at least 0.4% of 
all Lombard children under 6 years of age were hos-
pitalized for episodes of RVGE, annually. The RVGE 
hospitalization rate found in Lombardy (419/100 000 
inhabitants) is greater than that found in other national 
studies in Italy [9, 12], but is in line with those of oth-
er regions [8, 10, 15] and with the estimates for Italy 
generated by mathematical prediction models (290-
565/100 000) [16]. It should be considered that the 
present estimates for Lombardy might be lower than 
the actual data; in fact, some authors have shown that 
only 65.26% of all RVGE are diagnosed or encoded cor-
rectly, and that therefore they underestimate the real 
burden [15, 17].
The results obtained through the HDD study confirm 
the epidemiological characteristics of RVGE hospital-
izations observed in previous studies in other part of 
Italy. The age group at higher risk of admission to hospi-
tal with RVGE were children of less than 24 months of 
age. The rate of RVGE hospitalization had shown a in-
crease trend up to the 12-24 months age-class, followed 
by a decrement. As expected, the youngest children 
was protective against RV thank to maternal antibody 
and the reduction in the rate of RVGE in the children 
over 2 years old could be linked with the develop of the 
children protective antibody after previously infection. 
Interesting, the rate of RVGE as well as AGE hospi-
talization was higher in male than in female children 
(p < 0.001). A clear seasonal distribution of cases was 
constantly revealed in all years investigated, with the 
Table 1
Age-specific rate of Rotavirus gastroenteritis (RVGE) hospitalizations among children aged 1-71 months in Lombardy, 2005-2011
 PD SD Total 
Age group 
(months)
RVGE Cumulative 
RVGE 
RVGE Cumulative 
RVGE 
RVGE Cumulative 
RVGE 
n. (%) n.     (%) n. (%) n. (%) n. (%) n. (%)
1-3 m 593 5.4 593 5.4 532 9.2 532 9.2 1125 6.7 1125 6.7
4-6 m 752 6.9 1345 12.3 591 10.2 1123 19.4 1343 8.0 2468 14.7
7-11 m 1847 16.9 3192 29.1* 1053 18.2 2176 37.7* 2900 17.3 5368 32.1
12-23 m 3647 33.3 6839 62.4 1787 30.9 3963 68.6 5434 32.5 10 802 64.5
24-35 m 1944 17.7 8783 80.1 822 14.2 4785 82.8 2766 16.5 13 568 81.1
36-47 m 1136 10.4 9919 90.5 556 9.6 5341 92.5 1692 10.1 15 260 91.2
48-59 m 642 5.9 10 561 96.4 266 4.6 5607 97.1 908 5.4 16 168 96.6
60-71 m 400 4.0 10 961 100 170 3.0 5777 100 570 3.4 16 738 100
Total 10 961 100 - - 5777 100 - - 16 738 100 - -
PD: primary diagnosis; SD: secondary diagnosis; *p < 0.001.
Table 2
Cases of Rotavirus gastroenteritis (RVGE) identified in primary and secondary diagnosis  by age of patients and season in Lombar-
dy, 2005-2011
Winter season (December-March)
PD SD Total
n. (%) n. (%) n. (%)
1 < months <11 1971 56.8 1498 43.2* 3469 100.0
12 < months <71 4812 77.7 1382 22.3** 6194 100.0
All ages 6783 71.2 2880 29.8 9663 100.0
Other seasons (April-November)
PD SD Total
n. (%) n. (%) n. (%)
1 < months < 11 1221 64.3 678 35.7* 1889 100.0
12 < months < 71 2957 57.1 2219 42.9** 5176 100.0
All ages 4178 59.1 2897 40.9 7075 100.0
*p < 0.001; ** p < 0.001; PD: primary diagnosis; SD: secondary diagnosis.
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greater rate collected between winter and early spring, 
peaking in February-March. 
The higher rate of RVGE cases identified in SD in 
children aged 1-11 months may suggest that patients 
within this age group had developed a hospital-acquired 
RV infection more frequently than the other, confirming 
previous findings [18]. In fact, considering the severe 
clinical picture usually associated with RV infection in 
children of less than 1 year, it is reasonable to assume 
that a PD of RV infection would have been recorded if 
it was present on admission. Interestingly, RVGE cases 
among children 1-11 months old were identified in SD 
more frequently during the winter season than in chil-
dren over 12 months (p < 0.001). It is known that cases 
of RVGE share a same seasonal trend as the respiratory 
syndromes due to influenza virus, respiratory syncytial 
virus (RSV) and others etiological agent, which cause 
hospitalization particularly of younger children. Thus, 
our findings of a higher risk of nosocomial RV infec-
tion among children 1-11 months old, particularly in 
the cold months, might reflect a higher rate of hospital 
admission in this age class due to respiratory disease, as 
suggested by other authors [19, 20]. 
In this study, NDGE hospitalizations (4786 cases, 
about 14% of overall AGE) presented epidemiological 
characteristics similar to those associated with RVGE. 
The trend of RVGE and NDGE by age classes and sea-
sonality was well overlapped.
In some European countries where vaccination has 
been in place since 2006, a significant reduction of 
both RVGE infections and hospital admissions has 
been demonstrated [21]; moreover, using mathemati-
cal models, Giammanco et al. [22] and Vitale et al. [23] 
has estimated that the introduction of mass vaccina-
tion in Italy would allow a significant saving for societal 
perspective costs without additional workload for the 
health-care service. 
Disease surveillance based on HDD data is retrospec-
tive and is characterized by a low sensitivity despite its 
high specificity [7]. Additional actions would be needed, 
including enrolment of “sentinel hospitals” which could 
provide both current data on admissions and stool sam-
ples for genotyping of circulating RV strains. 
Since 2008, the Lombardy region is part of the Rota-
Net-Italy Study Group [24], including “sentinel hospi-
tals” and research centers throughout the country and 
coordinated by the Istituto Superiore di Sanità and by 
the Ministry of Health. The RotaNet-Italy network is 
linked to the EuroRotaNet [25] providing genotyping 
data on the RV strains circulating in the Italian paediat-
ric population and investigating the possible emergence 
of imported, zoonotic or recombinant RV strains that 
might prove resistant to current vaccines and require 
re-evaluation of vaccine composition [26].
CONCLUSIONS
In conclusion, data obtained from the regional HDD 
indicate that RV were the major cause of AGE hospi-
talization in children in Lombardy in the period be-
tween January 2005 and December 2011. The disease 
presented a recurring peak of admissions to hospital in 
winter and early spring especially in children up to 2 
years of age, based on both primary and secondary di-
agnosis. Using the results of this study as a baseline, 
continuing HDD-based surveillance may be useful to 
assess the impact of RV vaccine on the epidemiology of 
RVGE before and after mass vaccination.
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